Direct Intramuscular Injection of Psv-Vegf165 Stimulates Collateral Vessels Development in a Rabbit Model with Hindlimb Ischemia

赵意平,施娅雪,张皓,张柏根,何天源,陈诗书
DOI: https://doi.org/10.3969/j.issn.0253-9934.2000.04.008
2000-01-01
Abstract:Objective To investigate an easier and safer method of gene therapy in treatment of ischemic arterial disease of the lower extremity. Methods Recombinant plasmid pSV VEGF165 constructed in vitro were directly injected into the ischemic hindlimb muscles in rabbit models. 30 days after the gene transfer, selective angiography was undertaken, the capillary density and ratio of capillary to muscle fiber were determined histochemically in the resected specimens. Results The capillary density and capillary to muscle fiber ratio were significantly higher in pSV VEGF165 transfected group than those in control group, which were particularly increased in shank of the hindlimbs. In angiography, collateral arteries were significantly increased in some ischemic hindlimbs of pSV VEGF165 transfected group than those of control group. Conclusion Direct intramusclar injection of pSV VEGF165 was a simple and efficient gene therapy method, which can significantly stimulate collateral vessels development in ischemic limbs.(Shanghai Med J, 2000, 23∶210 212)
What problem does this paper attempt to address?